Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SIRP-β1b Inhibitors

SIRP-β1b inhibitors are a class of chemical compounds specifically designed to target and block the function of the signal regulatory protein beta-1b (SIRP-β1b), a member of the SIRP family of transmembrane proteins. SIRP-β1b is known to be involved in immune cell communication, particularly in modulating the interactions between immune cells, such as macrophages and other cell types within the immune system. SIRP proteins generally act as regulatory molecules, mediating inhibitory or activating signals based on their interactions with ligands or other receptors. SIRP-β1b, unlike the more well-characterized SIRP-α, is an activating receptor, meaning it likely plays a role in triggering immune responses and enhancing immune cell activity. Inhibitors of SIRP-β1b are designed to interfere with this signaling by binding to its extracellular domains or other functional regions, blocking its interaction with ligands or downstream signaling components.

The development of SIRP-β1b inhibitors involves a detailed understanding of the protein's structure, including its immunoglobulin-like domains that are involved in ligand recognition and signaling. Structural biology tools such as molecular modeling, X-ray crystallography, and computational docking are employed to identify potential binding sites on SIRP-β1b where inhibitors can effectively attach and disrupt its activity. These inhibitors are typically small molecules designed to fit into these key regions, preventing SIRP-β1b from engaging in its normal signaling functions. Once synthesized, the inhibitors are tested using biochemical assays to evaluate their binding affinity, specificity, and ability to inhibit SIRP-β1b's function in vitro. By inhibiting SIRP-β1b, researchers can explore its precise role in immune cell regulation, particularly its contribution to activating immune responses. The study of these inhibitors offers valuable insights into the broader regulatory functions of the SIRP family and their involvement in immune signaling and cellular communication.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

NSC 87877

56990-57-9sc-204139
50 mg
$137.00
12
(1)

NSC 87877 is a small molecule inhibitor that binds to the intracellular domain of SIRP-β1b, disrupting its interaction with downstream signaling molecules.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

PP2 is a selective inhibitor of Src family kinases, which phosphorylate SIRP-β1b. Inhibiting Src kinases prevents SIRP-β1b phosphorylation.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin inhibits phosphatidylinositol 3-kinase (PI3K), a downstream effector of SIRP-β1b signaling. Inhibiting PI3K disrupts downstream pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a specific inhibitor of p38 MAPK, a downstream kinase in the SIRP-β1b signaling pathway. Inhibiting p38 MAPK disrupts the signaling cascade.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a selective inhibitor of MEK1/2, upstream kinases in the MAPK/ERK pathway activated by SIRP-β1b. Inhibiting MEK1/2 blocks pathway activation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, a downstream effector of SIRP-β1b signaling. Inhibiting PI3K disrupts downstream pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a selective inhibitor of JNK, a downstream kinase in the MAPK pathway activated by SIRP-β1b. Inhibiting JNK disrupts the signaling cascade.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a selective inhibitor of MEK1/2, upstream kinases in the MAPK/ERK pathway activated by SIRP-β1b. Inhibiting MEK1/2 blocks pathway activation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits the mTOR pathway downstream of SIRP-β1b signaling. Inhibiting mTOR disrupts downstream pathways.